ECNP consensus meeting March 2003 guidelines for the investigation of efficacy in substance use disorders
| Autor: | S.A. Montgomery, J. M. Van Ree, B.J. van Zwieten-Boot, W. van den Brink |
|---|---|
| Přispěvatelé: | Amsterdam Neuroscience, Adult Psychiatry |
| Rok vydání: | 2005 |
| Předmět: |
medicine.medical_specialty
Substance-Related Disorders media_common.quotation_subject Alternative medicine Cost of Illness mental disorders Medicine Humans Pharmacology (medical) Psychiatry Biological Psychiatry media_common Randomized Controlled Trials as Topic Pharmacology Clinical Trials as Topic business.industry Addiction Psychiatry and Mental health Treatment Outcome Neurology Diagnosis Dual (Psychiatry) Research Design Neurology (clinical) Substance use business Clinical psychology |
| Zdroj: | European neuropsychopharmacology, 16(3), 224-230. Elsevier |
| ISSN: | 0924-977X |
| Popis: | Until recently, addiction was often perceived as representing some kind of immoral behaviour on the part of psychologically immature individuals with a marked tendency towards criminality. The recognition that addiction is a mental disorder was assisted by the introduction of a substance use disorders section in the third edition of the Diagnostic and Statistical Manual of mental disorders (DSMIII) (American Psychiatric Association, 1980). The description makes clear that addiction brepresents a clinically signifi |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Full Text from ScienceDirect